These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 31436)

  • 1. Circling induced by dopamine uptake inhibitors.
    Duvoisin RC; Heikkila RE; Manzino L
    J Pharm Pharmacol; 1978 Nov; 30(11):714-6. PubMed ID: 31436
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine-induced changes in striatal dopamine and acetylcholine levels and relationship to rotation (circling behavior) in rats.
    Glick SD; Jerussi TP; Water DH; Green JP
    Biochem Pharmacol; 1974 Nov; 23(22):3223-5. PubMed ID: 4474884
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of morphine-elicited circling by dopaminergic uptake blockade.
    Gratton A; Hoffer BJ; Gerhardt GA; Wise RA
    Pharmacol Biochem Behav; 1988 Aug; 30(4):1077-9. PubMed ID: 3227032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway.
    Oberlander C; Euvrard C; Dumont C; Boissier JR
    Eur J Pharmacol; 1979 Dec; 60(2-3):163-70. PubMed ID: 575095
    [No Abstract]   [Full Text] [Related]  

  • 6. Potassium-induced release of [3H]catecholamine from brain: effects of pre-exposure to catecholamine uptake inhibitors.
    Dembiec D; Cohen G
    J Pharmacol Exp Ther; 1981 Jun; 217(3):727-32. PubMed ID: 7230001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mazindol, nomifensine and desmethylimipramine inhibit potassium-induced release of dopamine: effect of stimulus strength.
    Dembiec-Cohen D
    J Neural Transm (Vienna); 1998; 105(6-7):735-47. PubMed ID: 9826115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-induced circling behaviour in MPTP-lesioned mice.
    Fung YK; Troxel CE
    J Pharm Pharmacol; 1985 Dec; 37(12):922-3. PubMed ID: 2868107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats.
    Asher IM; Aghajanian GK
    Brain Res; 1974 Dec; 82(1):1-12. PubMed ID: 4373138
    [No Abstract]   [Full Text] [Related]  

  • 10. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Heikkila RE; Cabbat FS; Manzino L; Babington RG; Houlihan WJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):745-9. PubMed ID: 7194909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Dec; 29(2):206-22. PubMed ID: 4613561
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of blocking catecholamine uptake on amphetamine-induced circling behaviour in mice with unilateral destruction of striatal dopaminergic nerve terminals.
    Pycock C; Milson JA; Tarsy D; Marsden CD
    J Pharm Pharmacol; 1976 Jun; 28(6):530-2. PubMed ID: 7659
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.
    Heikkila RE; Cabbat FS; Mytilineou C
    Eur J Pharmacol; 1977 Oct; 45(4):329-33. PubMed ID: 923643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 15. Repeated mazindol and methamphetamine administration produces cross-sensitization to stereotyped behavior induced by these agents in rats.
    Kawakami Y; Suemaru K; Araki H; Kawasaki H; Gomita Y; Tanizaki Y
    Acta Med Okayama; 1998 Jun; 52(3):169-71. PubMed ID: 9661745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat.
    Cadet JL; Zhu SM
    Brain Res; 1992 Nov; 595(2):316-26. PubMed ID: 1467973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats.
    Nakachi N; Kiuchi Y; Inagaki M; Inazu M; Yamazaki Y; Oguchi K
    Eur J Pharmacol; 1995 Aug; 281(2):195-203. PubMed ID: 7589207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
    Braestrup C; Scheel-Krüger J
    Eur J Pharmacol; 1976 Aug; 38(2):305-12. PubMed ID: 986308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of carbon disulphide on the stereotypic effect of dopamine agonists.
    Magos L
    Eur J Pharmacol; 1976 Mar; 36(1):257-8. PubMed ID: 944133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone does not alter amphetamine-induced rotational behavior or striatal dopamine levels of nigrally-lesioned rats.
    Kimmel HL; Schad CA; Justice JB; Holtzman SG
    Brain Res; 1998 Apr; 789(1):171-4. PubMed ID: 9602114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.